Molecular basis of prostanoid receptor-mediated pathogenesis and its drug application

前列腺素受体介导发病机制的分子基础及其药物应用

基本信息

  • 批准号:
    12557211
  • 负责人:
  • 金额:
    $ 8.51万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Results obtained by Kyoto University Group(1) Elucidation of patho-physiological roles of prostanoids by using each receptor-deficient mice :We found that EP2 deficiency attenuated intestinal polyp formation both in number and size in-Apc KO mice. We also showed acceleration of COX-2, EP2 and VEGF expression in the intestinal polyps of wild-type mice, but faint expression of COX-2 or VEGF in those of EP2 and Ape double-knockout mice, suggesting that there exists positive feedback regulation between COX-2 and EP2. We introduced dextransulfate (DSS)-induced colitis model into EP-deficient mice. As a result, only EP4-deficient mice showed severe colitis upon 3%DSS treatment that did not induce significant colitisin wild-type mice. EP4 has been shown to promote epithelial regeneration and to inhibit activation of leukocytes and lymphocytes.(2) The new signal transduction pathway exerted by prostanoid receptor EP3 :EP3 has been shown to be coupled to Gi activity, inhibition of adenylate cyc … More lase. EP3 has multiple isoforms that are different in their C-terminal structure and in their agonist-dependent Gi activity. We found that EP3 receptors expressed in COS-7 cells showed augmentation of other receptor-stimulated Gs activity in an agonist-dependent manner. The superactivation of Gs by EP3 receptors was not affected by the treatment of pertussis toxin, suggesting that the superactivation is not Gi-mediated. The EP3 agonist-dependent supeactivation of Gs is observed in any type of mouse EP3 receptor isoforms, irrespective of C-termnal structure of EP3 receptor. This EP3 signaling may reflect some aspects of the physiological function of PGE2, such as pain sensation.]Results obtained by Ono Pharmaceutical Co. Group(3) Development of EP4 receptor-specific ligands :Improvement of EP4-receptor selectivity and the agonist activity by introduction of heteroatoms into the alpha chain of PGE1 was investigated. Of the compounds produced, 16-phenyl-omega-tetranor-3,7-dithiaPGE1 possessing moderate EP4-receptor selectivity and agonist activity, was identified as a new chemical lead for further optimization by modification of the aromatic moiety Based on the information, we also successfully generated an EP4-specific antagonist with a high selectivity. Less
京都大学课题组的研究结果:(1)利用各受体缺陷小鼠阐明前列腺素的病理生理作用:我们发现EP2缺乏在-APC KO小鼠肠息肉形成的数量和大小上都有所减少。野生型小鼠肠息肉组织中COX-2、EP2和血管内皮生长因子表达加速,而EP2和APE双基因敲除小鼠肠息肉组织中COX-2和VEGF表达较弱,提示COX-2和EP2之间存在正反馈调节。我们将葡萄糖转硫酸盐(DSS)诱导的结肠炎模型引入EP缺陷小鼠。结果,只有EP4基因缺陷的小鼠在3%的DSS治疗下表现出严重的结肠炎,而在野生型小鼠中没有引起明显的结肠炎。EP4可促进上皮再生,抑制白细胞和淋巴细胞的激活。(2)前列腺素受体EP3:EP3发挥的新的信号转导途径与胃肠道活动、抑制腺苷环化…有关再来点激光。EP3有多种不同的异构体,它们的C末端结构和激动剂依赖的GI活性不同。我们发现,在COS-7细胞中表达的EP3受体以激动剂依赖的方式表现出其他受体刺激的Gs活性的增强。百日咳毒素处理不影响EP3受体对Gs的过度激活,提示这种过度激活不是由Gi介导的。在任何类型的小鼠EP3受体亚型中都可以观察到EP3激动剂依赖的Gs的过度激活,而与EP3受体的C-末端结构无关。这种EP3信号可能反映了PGE2生理功能的某些方面,如痛觉。]小野制药公司获得的结果(3)EP4受体特异性配体的开发:通过将杂原子引入PGE1的阿尔法链,研究了EP4受体选择性和激动剂活性的改善。在所合成的化合物中,16-苯基-欧米伽-四氢-3,7-二硫-PGE1具有中等的EP4受体选择性和激动剂活性,被鉴定为一种新的化学先导化合物,通过对芳香族部分的修饰,我们还成功地合成了一种高选择性的EP4特异性拮抗剂。较少

项目成果

期刊论文数量(48)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ma H, Hara A, Xiao CY, et al.: "Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP3"Circulation. 104. 1176-1180 (2001)
Ma H、Hara A、Xiao CY 等人:“缺乏前列腺素 E 受体亚型 EP3 的小鼠出血倾向增加,血栓栓塞的易感性降低”循环。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hatae, N., et al.: "Augmentation of Receptor-Mediated Adenylyl Cyclase Activity by Gi-Coupled Prostaglandin Receptor Subtype EP3 in a Gβγ Subunit-Independent Manner"Biochem. Biophys. Res. Commun.. 290. 162-168 (2002)
Hatae,N.,等人:“Gi 偶联前列腺素受体亚型 EP3 以不依赖 Gβγ 亚基的方式增强受体介导的腺苷酸环化酶活性”Biochem. 290. 162-168 (2002) )
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hatae, N., Yamaoka, K., Sugimoto, et al.: "Augmentation of Receptor-Mediated Adenylyl Cyclase Activity by Gi-Coupled Prostaglandin Receptor Subtype EP3 in a Gβγ Subunit-Independent Manner"Biochem.Biophys.Res.Commun.. 290. 162-168 (2002)
Hatae, N.、Yamaoka, K.、Sugimoto 等人:“Gi 偶联前列腺素受体亚型 EP3 以 Gβγ 亚基独立方式增强受体介导的腺苷酸环化酶活性”Biochem.Biophys.Res.Commun. 290. 162-168 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Croy,B.A., et al.: "Prolonged gestation dose not extend survival of uterine natural killer lymphocytes in mice deleted in the receptor for prostaglandin F_<2α>."J.Reprod.Immunol.. 46. 125-129 (2000)
Croy, B.A. 等人:“在前列腺素 F_<2α> 受体缺失的小鼠中,延长妊娠不会延长子宫自然杀伤淋巴细胞的存活时间。”J.Reprod.Immunol.. 46. 125-129 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsuboi,K., et al.: "Uterine expression of prostaglandin H_2 synthase in late pregnancy and during parturition in prostaglandin F receptor-deficient mice"Endocrinology. 141. 315-324 (2000)
Tsuboi,K., et al.:“前列腺素 F 受体缺陷小鼠妊娠晚期和分娩过程中前列腺素 H_2 合酶的子宫表达”内分泌学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ICHIKAWA Atsushi其他文献

ICHIKAWA Atsushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ICHIKAWA Atsushi', 18)}}的其他基金

Mechanisms for adhesion and leakage of pge_2-activated mast cells to and from extracellular matrix
pge_2激活的肥大细胞与细胞外基质的粘附和渗漏机制
  • 批准号:
    17590079
  • 财政年份:
    2005
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study for role of PGE2 on adhesion of mast cells to fibronectin
PGE2对肥大细胞与纤连蛋白粘附作用的研究
  • 批准号:
    15390024
  • 财政年份:
    2003
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Biopharmaceutical Research on Prostaglandin Receptors
前列腺素受体生物制药研究
  • 批准号:
    12470496
  • 财政年份:
    2000
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A study for drug-discovery based on physiological actions of prostanoid receptors
基于前列腺素受体生理作用的药物发现研究
  • 批准号:
    10557222
  • 财政年份:
    1998
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Function of prostaglandins and histamine in proliferation and differentiation of mast cells.
前列腺素和组胺在肥大细胞增殖和分化中的作用。
  • 批准号:
    09307052
  • 财政年份:
    1997
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis of mechanism of functions mediated by receptors of arachodonate cascade
花生四烯酸级联受体介导的功能机制分析
  • 批准号:
    07407080
  • 财政年份:
    1995
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Pharmaceutical approaches using prostanoid receptor knockout mice
使用前列腺素受体敲除小鼠的制药方法
  • 批准号:
    07557156
  • 财政年份:
    1995
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Structures and Functions of Prostaglandin Receptors
前列腺素受体的结构和功能
  • 批准号:
    05454568
  • 财政年份:
    1993
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
A study for gene expression of synthetic enzymes and receptors for lipid biofactors
脂质生物因子合成酶和受体基因表达的研究
  • 批准号:
    05304027
  • 财政年份:
    1993
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Co-operative Research (A)
New assay systems for the development of inhibitory drugs against activated mast cell function
用于开发针对激活的肥大细胞功能的抑制药物的新测定系统
  • 批准号:
    04557108
  • 财政年份:
    1992
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)

相似海外基金

SIGNAL TRANSDUCTION OF THE D2 DOPAMINE RECEPTOR SUBTYPES
D2 多巴胺受体亚型的信号转导
  • 批准号:
    2267205
  • 财政年份:
    1991
  • 资助金额:
    $ 8.51万
  • 项目类别:
SIGNAL TRANSDUCTION OF THE D2 DOPAMINE RECEPTOR SUBTYPES
D2 多巴胺受体亚型的信号转导
  • 批准号:
    6126227
  • 财政年份:
    1991
  • 资助金额:
    $ 8.51万
  • 项目类别:
SIGNAL TRANSDUCTION OF THE D2 DOPAMINE RECEPTOR SUBTYPES
D2 多巴胺受体亚型的信号转导
  • 批准号:
    2267204
  • 财政年份:
    1991
  • 资助金额:
    $ 8.51万
  • 项目类别:
SIGNAL TRANSDUCTION OF THE D2 DOPAMINE RECEPTOR SUBTYPES
D2 多巴胺受体亚型的信号转导
  • 批准号:
    2839334
  • 财政年份:
    1991
  • 资助金额:
    $ 8.51万
  • 项目类别:
SIGNAL TRANSDUCTION OF THE D2 DOPAMINE RECEPTOR SUBTYPES
D2 多巴胺受体亚型的信号转导
  • 批准号:
    2503714
  • 财政年份:
    1991
  • 资助金额:
    $ 8.51万
  • 项目类别:
SIGNAL TRANSDUCTION OF THE D2 DOPAMINE RECEPTOR SUBTYPES
D2 多巴胺受体亚型的信号转导
  • 批准号:
    3478121
  • 财政年份:
    1991
  • 资助金额:
    $ 8.51万
  • 项目类别:
SIGNAL TRANSDUCTION OF THE D2 DOPAMINE RECEPTOR SUBTYPES
D2 多巴胺受体亚型的信号转导
  • 批准号:
    6330446
  • 财政年份:
    1991
  • 资助金额:
    $ 8.51万
  • 项目类别:
SIGNAL TRANSDUCTION OF THE D2 DOPAMINE RECEPTOR SUBTYPES
D2 多巴胺受体亚型的信号转导
  • 批准号:
    3478122
  • 财政年份:
    1991
  • 资助金额:
    $ 8.51万
  • 项目类别:
SIGNAL TRANSDUCTION OF THE D2 DOPAMINE RECEPTOR SUBTYPES
D2 多巴胺受体亚型的信号转导
  • 批准号:
    3478120
  • 财政年份:
    1991
  • 资助金额:
    $ 8.51万
  • 项目类别:
Functional Interaction Between Adrenergic Receptor Subtypes In the intracellular Signal Transduction.
细胞内信号转导中肾上腺素能受体亚型之间的功能相互作用。
  • 批准号:
    01570110
  • 财政年份:
    1989
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了